Hospice For Sale in Texas – Medicare & Medicaid
Hospice For Sale in Texas – Medicare & Medicaid
Based in the Greater Houston Area
Entire state coverage
Census 16
Accredited through the state
Medicare & Medicaid Certified
will pass 36 month rule October 2025
Asking Price: $700K
Reference Number: 35461925930
Contact Vallexa Advisors: 586-623-5616
Cash equivalent to purchase price set aside to invest from currently available funds required
– Healthcare-specific industry experience required –
View other available healthcare opportunities by clicking HERE
Thinking of selling YOUR healthcare agency? Find out how by clicking HERE
Texas Hospice – Frequently Asked Questions
Where is the agency based and what is the service area?
What is the current patient census?
Is the hospice accredited and which payors are in place?
Does this sale include real estate?
What is the status of the 36-month rule?
Will the seller provide transition support?
What is the asking price and reference number?
Reference #: 35461925930
How do I request more information?
Read More: Highlights & Details
Snapshot
- Texas Hospice based in Stafford with entire state coverage
- Census: 16
- Accredited through the state; Medicare & Medicaid certified
- 36-Month Rule: eligible October 2025
- Asking Price: $700,000
- Reference #: 35461925930
Facilities & Assets
Professional office base in Stafford enabling statewide operations. No real estate included. Sale comprises licenses, accreditation status, policies & procedures, EMR/operational framework, and goodwill.
Support & Training
Seller to provide a structured transition covering regulatory compliance, clinical operations, billing & payor processes, and introductions to key referral relationships.
Market & Competition
Texas is a high-demand hospice market with robust demographics. This agency differentiates with statewide coverage, state accreditation, and Medicare/Medicaid certification—positioning it competitively for organic and inorganic growth.
Growth & Expansion
- Scale referral partnerships (hospitals, SNFs, home health, PCPs)
- Expand clinical staffing to support census growth beyond 16
- Enhance community outreach and digital presence
- Capitalize on 36-month rule milestone in October 2025 for strategic M&A moves
Note: Details are believed accurate but not guaranteed. Buyers should verify all information during diligence.
Interested in This Opportunity?
Contact Vallexa Advisors today to learn more about this listing and schedule a confidential consultation.
All inquiries are kept strictly confidential
